Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses

被引:24
作者
Chen, D [1 ]
Zuleger, C [1 ]
Chu, Q [1 ]
Maa, YF [1 ]
Osorio, J [1 ]
Payne, LG [1 ]
机构
[1] PowderJect Vaccines Inc, Madison, WI 53711 USA
关键词
D O I
10.1089/088922202760072348
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The recombinant envelope gp120 (rgp120) of human immunodeficiency virus (HIV) is a weak immunogen when administered by intramuscular (IM) injection. In the present study, we report that epidermal powder immunization (EPI) elicits robust antibody responses to the rgp120. EPI of mice with a dose 0.2-5 mug of rgp120 protein elicited geometric mean antibody titers that were 18- to 240-fold higher than that elicited by IM injection using a 5.0 mug dose. Targeting antigen to and mobilization of Langerhans cells (LCs) by EPI may explain the enhanced immunogenicity of the rgp120. EPI with rgp120 using sugar and gold particles as carrier resulted in differential antigen entry into the LCs and differential IgG subclass antibody and cellular immune responses. EPI may serve as a useful tool to evaluate vaccine potential of the rgp120 protein.
引用
收藏
页码:715 / 722
页数:8
相关论文
共 28 条
[1]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[2]   Adjuvantation of epidermal powder immunization [J].
Chen, DX ;
Erickson, CA ;
Endres, RL ;
Periwal, SB ;
Chu, QL ;
Shu, C ;
Maa, YF ;
Payne, LG .
VACCINE, 2001, 19 (20-22) :2908-2917
[3]   Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization [J].
Chen, DX ;
Periwal, SB ;
Larrivee, K ;
Zuleger, C ;
Erickson, CA ;
Endres, RL ;
Payne, LG .
JOURNAL OF VIROLOGY, 2001, 75 (17) :7956-7965
[4]   Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses [J].
Chen, DX ;
Weis, KF ;
Chu, QL ;
Erickson, C ;
Endres, R ;
Lively, CR ;
Osorio, J ;
Payne, LG .
JOURNAL OF VIROLOGY, 2001, 75 (23) :11630-11640
[5]   Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice [J].
Chen, DX ;
Endres, RL ;
Erickson, CA ;
Weis, KF ;
McGregor, MW ;
Kawaoka, Y ;
Payne, LG .
NATURE MEDICINE, 2000, 6 (10) :1187-1190
[6]   DISTRIBUTION OF ATPASE-POSITIVE LANGERHANS CELLS IN NORMAL ADULT HUMAN-SKIN [J].
CHEN, H ;
YUAN, J ;
WANG, Y ;
SILVERS, WK .
BRITISH JOURNAL OF DERMATOLOGY, 1985, 113 (06) :707-711
[7]   CELL-MEDIATED IMMUNE-RESPONSE TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 IN SERONEGATIVE HOMOSEXUAL MEN WITH RECENT SEXUAL EXPOSURE TO HIV-1 [J].
CLERICI, M ;
GIORGI, JV ;
CHOU, CC ;
GUDEMAN, VK ;
ZACK, JA ;
GUPTA, P ;
HO, HN ;
NISHANIAN, PG ;
BERZOFSKY, JA ;
SHEARER, GM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (06) :1012-1019
[8]   Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines [J].
Connor, RI ;
Korber, BTM ;
Graham, BS ;
Hahn, BH ;
Ho, DD ;
Walker, BD ;
Neumann, AU ;
Vermund, SH ;
Mestecky, J ;
Jackson, S ;
Fenamore, E ;
Cao, Y ;
Gao, F ;
Kalams, S ;
Kunstman, KJ ;
McDonald, D ;
McWilliams, N ;
Trkola, A ;
Moore, JP ;
Wolinsky, SM .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1552-1576
[9]  
DADAGLIO G, 1991, J IMMUNOL, V147, P2302
[10]   Priming of cytotoxic T lymphocytes by DNA vaccines: Requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes [J].
Fu, TM ;
Ulmer, JB ;
Caulfield, MJ ;
Deck, RR ;
Friedman, A ;
Wang, S ;
Liu, X ;
Donnelly, JJ ;
Liu, MA .
MOLECULAR MEDICINE, 1997, 3 (06) :362-371